장
장윤수 Directeur Exécutif
Other M
KR KR · DART (FSS)
Browse the complete record of transactions filed by 장윤수, Directeur Exécutif. Officer active across 2 companies, notably 명문제약. Aggregated, 29 reports have been recorded. The latest transaction was filed on 30 April 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Declarations 29 total
Executives ● Purchase명 명문제약 12 DART DART:20260430000426 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 12 DART DART:20260430000104 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 12 DART DART:20260430000081 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 3 DART €11,558 11,184 shares
DART:20260430000394 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000283 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 12 DART DART:20260429000532 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000321 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000316 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000311 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) DART:20260331001874 · 31 Mar 2026
DART:20260331001463 · 31 Mar 2026
Executives ● Other명 명문제약 0 DART DART:20260311003642 · 11 Mar 2026 details not loaded
DART:20260306000545 · 6 Mar 2026 details not loaded
Executives ● Other명 명문제약 0 DART DART:20220311000642 · 11 Mar 2022 details not loaded
Executives ● Purchase명 명문제약 0 DART 116,303 shares
DART:20220303000101 · 3 Mar 2022
Ideal exit: 28 Nov 2022 (T+270) Executives ● Purchase명 명문제약 0 DART 116,303 shares
DART:20220216000904 · 16 Feb 2022
Ideal exit: 13 Nov 2022 (T+270) Executives ● Purchase명 명문제약 0 DART 116,303 shares
DART:20211209000087 · 9 Dec 2021
Ideal exit: 5 Sept 2022 (T+270) Executives ● Purchase명 명문제약 0 DART 116,303 shares
DART:20211206000324 · 6 Dec 2021
Ideal exit: 2 Sept 2022 (T+270) Executives ● Purchase명 명문제약 0 DART DART:20211202000337 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) Executives ● Purchase명 명문제약 0 DART 116,303 shares
DART:20211124000086 · 24 Nov 2021
Ideal exit: 21 Aug 2022 (T+270) Executives ● Purchase명 명문제약 0 DART DART:20211124000082 · 24 Nov 2021
Ideal exit: 21 Aug 2022 (T+270) Executives ● Purchase명 명문제약 0 DART DART:20211122000081 · 22 Nov 2021
Ideal exit: 19 Aug 2022 (T+270) Executives ● Purchase명 명문제약 0 DART DART:20211122000082 · 22 Nov 2021
Ideal exit: 19 Aug 2022 (T+270) Executives ● Purchase명 명문제약 0 DART DART:20211022000097 · 22 Oct 2021
Ideal exit: 19 Jul 2022 (T+270) Executives ● Purchase명 명문제약 0 DART DART:20210913000116 · 13 Sept 2021
Ideal exit: 10 Jun 2022 (T+270) 25 of 29 declarations
Load more (4 remaining) About 장윤수 Jang Yoon-soo is an Executive Director at 명문제약. He is responsible for overseeing operations and implementing the company's strategies. His experience and leadership are essential for achieving the organization's growth and innovation objectives.